Simpler Grants.gov #PAR-25-175

NCI Grant for Integrating Imaging and Liquid Biopsy in Cancer Therapy Research

This opportunity from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), seeks research projects focused on integrating imaging and fluid-based tumor monitoring during cancer therapy. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Products/Services Requested: - Research services to integrate imaging and liquid biopsy assays in cancer therapy - Focus on determining optimal use for characterizing therapy response and resistance - OEMs and Vendors: - No specific OEMs or vendors are mentioned - Unique/Notable Requirements: - Projects must combine imaging and fluid-based (liquid biopsy) monitoring - Open to a wide range of eligible organizations (educational, business, government, nonprofit) - Falls under cancer research-related assistance listings (93.393, 93.395, 93.394) - Funding amount is $500,000

Description

This funding opportunity from the National Cancer Institute (NCI) seeks research project (R01) grant applications that focus on integrating imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy. The projects aim to determine the optimal use of these modalities in characterizing therapy response and resistance in patients. The opportunity is open to a wide range of eligible applicants, including educational institutions, businesses, government entities, and nonprofits. The deadline for application submission is January 7, 2028, with a funding amount of $500,000.

View original listing